Risk assessment for recurrent venous thrombosis

The Lancet

Volumn 376, Issue 9757, 2010, Pages 2032-2039

  Kyrle, Paul Alexander ^a,b   Rosendaal, Frits R ^c   Eichinger, Sabine ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute of Thrombosis Research   (Austria)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER;

BLEEDING; CLINICAL FEATURE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; VEIN THROMBOSIS;

EID: 78650172730     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60962-2     Document Type: Review

References (97)

1. PA Kyrle, S Eichinger Deep vein thrombosis Lancet 365 2005 1163 1174
2. IA Naess, SC Christiansen, P Romundstad, SC Cannegieter, FR Rosendaal, J Hammerstrøm Incidence and mortality of venous thromboembolism: a population-based study J Thromb Haemost 5 2007 692 699
3. SZ Goldhaber Pulmonary embolism Lancet 363 2004 1295 1305
4. JA Heit, MD Silverstein, DN Mohr The epidemiology of venous thromboembolism in the community Thromb Haemost 86 2001 452 463
5. D Aujesky, DS Obrosky, RA Stone A prediction rule to identify low-risk patients with pulmonary embolism Arch Intern Med 166 2006 169 175
6. PO Hansson, J Sörbo, H Eriksson Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors Arch Intern Med 160 2000 769 774
7. P Prandoni, F Noventa, A Ghirarduzzi The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients Haematologica 92 2007 199 205
8. L Eischer, S Eichinger, PA Kyrle Age at first venous thromboembolism and risk of recurrence: a prospective cohort study Medicine (Baltimore) 88 2009 366 370
9. JD Douketis, CS Gu, S Schulman, A Ghirarduzzi, V Pengo, P Prandoni The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism Ann Intern Med 147 2007 766 774
10. M Carrier, G Le Gal, PS Wells, MA Rodger Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism Ann Intern Med 152 2010 578 589
11. LA Linkins, PT Choi, JD Douketis Clinical Impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism Ann Intern Med 139 2003 893 900
12. DA McMahan, DM Smith, MA Carey, XH Zhou Risk of major hemorrhage for outpatients treated with warfarin J Gen Intern Med 13 1998 311 316
13. RJ Beyth, L Quinn, CS Landefeld A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomised, controlled trial Ann Intern Med 133 2000 687 695
14. S Eichinger, G Heinze, LM Jandeck, PA Kyrle Risk assessment of recurrence in patients with unprovoked deep model vein thrombosis or pulmonary embolism: the Vienna prediction model Circulation 121 2010 1630 1636
15. T Baglin, R Luddington, K Brown, C Baglin Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study Lancet 362 2003 523 526
16. S Eichinger, A Weltermann, E Minar Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism Arch Intern Med 164 2004 92 96 (Pubitemid 38067394)
17. D Jiménez, G Diaz, E Marin, R Vidal, A Sueiro, RD Yusen The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism Thromb Haemost 95 2006 562 566
18. PM Ridker, SZ Goldhaber, E Danielson for the PREVENT Investigators Long-term, low intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 2003 1425 1434
19. PA Kyrle, E Minar, C Bialonczyk, M Hirschl, A Weltermann, S Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 2004 2558 2563
20. S McRae, H Tran, S Schulman, J Ginsberg, C Kearon Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis Lancet 368 2006 371 378
21. S Siragusa, A Malato, R Anastasio Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study Blood 112 2008 511 515
22. P Prandoni, MH Prins, AW Lensing for the AESOPUS investigators Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial Ann Intern Med 150 2009 577 585
23. P Prandoni, AW Lensing, MH Prins Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism Ann Intern Med 137 2002 955 960
24. SC Christiansen, SC Cannegieter, T Koster, JP Vandenbroucke, FR Rosendaal Thrombophilia, clinical factors, and recurrent venous thrombotic events JAMA 293 2005 2352 2361
25. E Hoibraaten, E Qvigstad, H Arnesen, S Larsen, E Wickstrom, PM Sandset Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomised, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thromb Haemost 84 2000 961 967
26. P Prandoni, AW Lensing, A Piccioli Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 2002 3484 3488
27. AY Lee, MN Levine, RI Baker for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153
28. M Stain, V Schönauer, E Minar The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease J Thromb Haemost 3 2005 2671 2676
29. S Eichinger, G Hron, C Bialonczyk Overweight, obesity, and the risk of recurrent venous thromboembolism Arch Intern Med 168 2008 1678 1683
30. C Kearon, JS Ginsberg, DR Anderson for the SOFAST Investigators Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor J Thromb Haemost 2 2004 743 749
31. MA Rodger, SR Kahn, PS Wells Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy CMAJ 179 2008 417 426
32. R Hull, T Delmore, E Genton Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis N Engl J Med 301 1979 855 858
33. S Schulman, AS Rhedin, P Lindmarker the Duration of Anticoagulation Trial Study Group A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism N Engl J Med 332 1995 1661 1665
34. JP Galanaud, S Quenet, K Rivron-Guillot Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients J Thromb Haemost 7 2009 2028 2034
35. S Murin, PS Romano, RH White Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism Thromb Haemost 88 2002 407 414
36. G Agnelli, P Prandoni, C Becattini Warfarin Optimal Duration Italian Trial Investigators Extended oral anticoagulant therapy after a first episode of pulmonary embolism Ann Intern Med 139 2003 19 25
37. S Schulman, S Granqvist, M Holmström for the Duration of Anticoagulation Trial Study Group The duration of oral anticoagulant therapy after a second episode of venous thromboembolism N Engl J Med 336 1997 393 398 (Pubitemid 27081901)
38. S Schulman, K Wählander, T Lundström, SB Clason, H Eriksson for the THRIVE III Investigators Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran N Engl J Med 349 2003 1713 1721 (Pubitemid 37315008)
39. S Schulman, P Lindmarker, M Holmström Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months J Thromb Haemost 4 2006 734 742
40. RJ Beyth, AM Cohen, CS Landefeld Long-term outcomes of deep-vein thrombosis Arch Intern Med 155 1995 1031 1037
41. RH White, H Zhou, PS Romano Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism Arch Intern Med 158 1998 1005 1010
42. G Hron, R Lombardi, S Eichinger, A Lecchi, PA Kyrle, M Cattaneo Family history for venous thromboembolism and the risk for recurrence Am J Med 119 2006 50 53
43. S Eichinger, NM Pecheniuk, G Hron High-density lipoprotein and the risk of recurrent venous thromboembolism Circulation 115 2007 1609 1614 (Pubitemid 46648646)
44. R Marcucci, AA Liotta, AP Cellai Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism Am J Med 115 2003 601 605
45. G Ruiz-Irastorza, BJ Hunt, MA Khamashta A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies Arthritis Rheum 57 2007 1487 1495
46. MA Khamashta, MJ Cuadrado, F Mujic, NA Taub, BJ Hunt, GR Hughes The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
47. S Schulman, E Svenungsson, S Granqvist the Duration of Anticoagulation Study Group Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy Am J Med 104 1998 332 338
48. F Piovella, L Crippa, M Barone Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis Haematologica 87 2002 515 522
49. PREPIC Study Group Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC randomized study Circulation 112 2005 416 422
50. RH White, H Zhou, J Kim, PS Romano A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism Arch Intern Med 160 2000 2033 2041
51. PA Kyrle, E Minar, M Hirschl High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 2000 457 462
52. RA Kraaijenhagen, PS in't Anker, MM Koopman High plasma concentration of factor VIII is a major risk factor for venous thromboembolism Thromb Haemost 83 2000 5 9
53. C Legnani, C Benilde, C Michela, F Mirella, G Giuliana, P Gualtiero High plasma levels of factor VIII and risk of recurrence of venous thromboembolism Br J Haematol 124 2004 504 510 (Pubitemid 38230597)
54. NA Goldenberg, R Knapp-Clevenger, MJ Manco-Johnson for the Mountain States Regional Thrombophilia Group Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children N Engl J Med 351 2004 1081 1088
55. A Weltermann, S Eichinger, C Bialonczyk The risk of recurrent venous thromboembolism among patients with high factor IX levels J Thromb Haemost 1 2003 28 32
56. S Eichinger, A Stümpflen, M Hirschl Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism Thromb Haemost 80 1998 566 569
57. M den Heijer, HP Willems, HJ Blom Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial Blood 109 2007 139 144
58. WK Ho, GJ Hankey, DJ Quinlan, JW Eikelboom Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review Arch Intern Med 166 2006 729 736
59. A Marchiori, L Mosena, MH Prins, P Prandoni The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica 92 2007 1107 1114
60. JB Segal, DJ Brotman, AJ Necochea Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review JAMA 301 2009 2472 2485
61. G Palareti, C Legnani, B Cosmi, G Guazzaloca, C Pancani, S Coccheri Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped Thromb Haemost 87 2002 7 12
62. G Palareti, C Legnani, B Cosmi Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia Circulation 108 2003 313 318
63. S Eichinger, E Minar, C Bialonczyk D-dimer levels and risk of recurrent venous thromboembolism JAMA 290 2003 1071 1074 (Pubitemid 37430448)
64. M Verhovsek, JD Douketis, Q Yi Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism Ann Intern Med 149 2008 481 490
65. E Bruinstroop, FA Klok, MA Van De Ree, FL Oosterwijk, MV Huisman Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis J Thromb Haemost 7 2009 611 618
66. G Palareti, B Cosmi, C Legnani for the PROLONG Investigators D-dimer testing to determine the duration of anticoagulation therapy N Engl J Med 355 2006 1780 1789
67. B Cosmi, C Legnani, A Tosetto for the PROLONG Investigators (on behalf of Italian Federation of Anticoagulation Clinics) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study Blood 115 2010 481 488
68. G Hron, M Kollars, BR Binder, S Eichinger, PA Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
69. S Eichinger, G Hron, M Kollars, PA Kyrle Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer Clin Chem 54 2008 2042 2048
70. A Tripodi, C Legnani, V Chantarangkul, B Cosmi, G Palareti, PM Mannucci High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism J Thromb Haemost 6 2008 1327 1333
71. M Besser, C Baglin, R Luddington, A van Hylckama Vlieg, T Baglin High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 2008 1720 1725
72. AG van den Belt, BJ Sanson, P Simioni Recurrence of venous thromboembolism in patients with familial thrombophilia Arch Intern Med 157 1997 2227 2232
73. V De Stefano, P Simioni, E Rossi The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S Haematologica 91 2006 695 708
74. JL Brouwer, WM Lijfering, MK Ten Kate, HC Kluin-Nelemans, NJ Veeger, J van der Meer High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin Thromb Haemost 101 2009 93 99
75. CY Vossen, ID Walker, P Svensson Recurrence rate after a first venous thrombosis in patients with familial thrombophilia Arterioscler Thromb Vasc Biol 25 2005 1992 1997
76. M Hoke, PA Kyrle, E Minar Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism Thromb Haemost 94 2005 787 790 (Pubitemid 41489238)
77. S Eichinger, V Schönauer, A Weltermann Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism Blood 103 2004 3773 3776 (Pubitemid 38596294)
78. B Jilma, FM Kovar, G Hron Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism Arch Intern Med 166 2006 1655 1659
79. S Mustafa, A Weltermann, R Fritsche Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism J Vasc Surg 47 2008 566 570
80. S Shrivastava, PM Ridker, RJ Glynn D-dimer, factor VIII coagulant activity, low intensity warfarin and the risk of recurrent venous thromboembolism J Thromb Haemost 4 2006 1208 1214
81. S Eichinger, I Pabinger, A Stümpflen The risk of recurrent venous thromboembolism in patients with and without factor V Leiden Thromb Haemost 77 1997 624 628
82. S Eichinger, E Minar, M Hirschl The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A mutation in the prothrombin gene Thromb Haemost 81 1999 14 17
83. 506→Gln mutation in the gene for factor V (factor V Leiden) N Engl J Med 336 1997 399 403
84. P Simioni, P Prandoni, AW Lensing Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis Blood 96 2000 3329 3333
85. WM Lijfering, S Middledorp, JGM Veeger Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A Circulation 121 2010 1706 1712
86. S Schulman, B Wiman The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group Thromb Haemost 75 1996 607 611
87. MA Crowther, J Roberts, R Roberts Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study Thromb Haemost 85 2001 390 394
88. U Seligsohn, A Lubetsky Genetic susceptibility to venous thrombosis N Engl J Med 344 2001 1222 1231
89. TM Hyers, G Agnelli, RD Hull Antithrombotic therapy for venous thromboembolic disease Chest 19 suppl 2001 176S 193S
90. C Kearon, JA Julian, MJ Kovacs for the ELATE investigators Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial Blood 112 2008 4432 4436
91. M Coppens, JH Reijnders, S Middeldorp, CJ Doggen, FR Rosendaal Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis J Thromb Haemost 6 2008 1474 1477
92. D Cohn, F Vansenne, C de Borgie, S Middeldorp Thrombophilia testing for prevention of recurrent venous thromboembolism Cochrane Database Syst Rev 1 2009 CD007069.
93. WL Chandler, C Ferrell, J Lee, T Tun, H Kha Comparison of three methods for measuring factor VIII levels in plasma Am J Clin Pathol 120 2003 34 39
94. T Baglin, E Gray, M Greaves Clinical guidelines for testing for heritable thrombophilia Br J Haematol 149 2010 209 220
95. G Hron, S Eichinger, A Weltermann, P Quehenberger, WM Halbmayer, PA Kyrle Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time J Thromb Haemost 4 2006 752 756
96. S Eichinger, G Hron, M Hirschl Prediction of recurrent venous thromboembolism by measuring ProC Global Thromb Haemost 98 2007 1232 1236
97. PA Kyrle, S Eichinger New diagnostic strategies for pulmonary embolism Lancet 371 2008 1312 1315